Nephrology Service, Hospital Británico de Buenos Aires, Perdriel 74, Buenos Aires, Argentina.
J Nephrol. 2010 Nov-Dec;23(6):725-31.
Acute renal failure due to viral infections is rare. We assessed the development of acute kidney injury (AKI) in critically compromised patients due to the H1N1 influenza virus.
All patients with a PCR -confirmed diagnosis of H1N1 influenza infection admitted to the intensive care unit between May and July 2009 were retrospectively studied. Thereafter, the risk factors associated with the development of acute renal injury, the requirements of acute hemodialysis (HD) and death were analyzed.
Twenty-two patients with H1N1 pneumonia were included: age: 52.91 ± 18.89 years; gender: males 11 (50%); chronic airway disease: 9 (41%); oncohematological disease: 8 (36.7%); cardiovascular disease 5 (22.7%); chronic renal insufficiency: 4 (18.2%); obesity 3 (13.6%); concomitant pregnancy: 2 (9.1%); diabetes mellitus: 2 (9.1%); previous influenza A vaccination: 9 (41%). All patients received oseltamivir within 48 hours of presumed diagnosis. Seventeen patients (77.3%) developed fever initially. Six patients (27.3%) required noninvasive ventilation assistance and 15 patients (68.2%) received invasive ventilatory support. Mean days on mechanical respiratory assistance: 11 ± 10.35. Arterial partial pressure of oxygen/fraction of inspired oxygen ratio: 140.11 ± 83.03 mmHg. Inotropic drugs were administered to 15 patients (68.2%). Fourteen patients (63.6%) developed AKI. Mean highest creatinine levels: 2.74 ± 2.83 mg/dl. Four patients (18.2%) needed renal replacement therapy with a mean duration of 15 ± 12 days. Six patients (42.9%) recovered renal function. AKI was associated with pregnancy, immunosuppression, high APAC HE, SOFA and MURRA Y scores, and less time on mechanical ventilation assistance, hemodynamical instability and thrombocytopenia. HD requirements were associated with elevated SOFA scores (12.25 ± 1.75 vs. 6.22 ± 0.8, p<0.05), elevated creatine phosphokinase (933 ± 436.6 vs. 189.9 ± 79.3 U/L, p<0.05) and alanine transferase levels (843.3 ± 778.8 vs. 85.33 ± 17.4 U/L, p<0.05). Twelve patients died (54.6%), 10 of whom had acute renal failure (83.3%) and 3 had been on acute HD (25%). Mortality was associated with higher APACHE, SOFA and Murray scores, a higher oseltamivir dose (253.1 ± 25.8 vs. 183.8 ± 27.6 mg, p<0.05), lower oxygen inspired fraction/alveolar pressure ratio (99.3 ± 12.2 vs. 196.3 ± 33.9 mmHg, p<0.01), thrombocytopenia (88966 ± 22977 vs. 141200 ± 17282 mm3, p<0.05), hypoalbuminemia (1.82 ± 0.1 vs. 2.61 ± 0.2 g/dl, p<0.01), acute renal failure (10 vs. 4, p<0.05), oligoanuria (5 vs. 0, p<0.05) and lack of recovery of renal function (2 vs. 4, p<0.01). Three out of 4 (75%) of the hemodialyzed patients died.
In the critically ill due to H1N1 pneumonia, renal insufficiency was a frequent complication, demanding renal replacement therapy in 18% of cases. The need for HD was associated with an elevated risk of death. Mortality was mainly associated with multiple organ failure, oligoanuria, acute renal injury and a lack of recovery of renal function.
由病毒感染引起的急性肾衰竭较为少见。我们评估了甲型 H1N1 流感病毒导致的危重病患者急性肾损伤(AKI)的发生情况。
回顾性分析 2009 年 5 月至 7 月间因甲型 H1N1 流感感染而入住重症监护病房的所有经 PCR 确诊的患者。此后,分析了与急性肾损伤发生相关的危险因素、急性血液透析(HD)的需求和死亡情况。
22 例甲型 H1N1 肺炎患者纳入研究:年龄 52.91 ± 18.89 岁;性别:男性 11 例(50%);慢性气道疾病 9 例(41%);血液肿瘤疾病 8 例(36.7%);心血管疾病 5 例(22.7%);慢性肾功能不全 4 例(18.2%);肥胖 3 例(13.6%);妊娠 2 例(9.1%);糖尿病 2 例(9.1%);既往接种过流感 A 疫苗 9 例(41%)。所有患者均在疑似诊断后 48 小时内接受了奥司他韦治疗。17 例患者(77.3%)最初出现发热。6 例患者(27.3%)需要无创通气辅助,15 例患者(68.2%)接受了有创通气支持。机械通气辅助的平均天数为 11 ± 10.35 天。动脉血氧分压/吸入氧分数比为 140.11 ± 83.03 mmHg。15 例患者(68.2%)使用了正性肌力药物。14 例患者(63.6%)发生 AKI。最高肌酐水平的平均值为 2.74 ± 2.83 mg/dl。4 例患者(18.2%)需要肾脏替代治疗,平均持续时间为 15 ± 12 天。6 例患者(42.9%)恢复了肾功能。AKI 与妊娠、免疫抑制、高 APAC HE、SOFA 和 MURRAY 评分以及机械通气辅助时间较短、血流动力学不稳定和血小板减少有关。HD 的需求与较高的 SOFA 评分(12.25 ± 1.75 与 6.22 ± 0.8,p<0.05)、较高的肌酸磷酸激酶(933 ± 436.6 与 189.9 ± 79.3 U/L,p<0.05)和丙氨酸转氨酶水平(843.3 ± 778.8 与 85.33 ± 17.4 U/L,p<0.05)相关。12 例患者死亡(54.6%),其中 10 例为急性肾衰竭(83.3%),3 例接受了急性 HD(25%)。死亡率与较高的 APACHE、SOFA 和 Murray 评分、更高的奥司他韦剂量(253.1 ± 25.8 与 183.8 ± 27.6 mg,p<0.05)、较低的氧吸入分数/肺泡压力比(99.3 ± 12.2 与 196.3 ± 33.9 mmHg,p<0.01)、血小板减少症(88966 ± 22977 与 141200 ± 17282 mm3,p<0.05)、低白蛋白血症(1.82 ± 0.1 与 2.61 ± 0.2 g/dl,p<0.01)、急性肾衰竭(10 例与 4 例,p<0.05)、少尿(5 例与 0 例,p<0.05)和肾功能无法恢复(2 例与 4 例,p<0.01)有关。4 例接受血液透析的患者中有 3 例(75%)死亡。
在因甲型 H1N1 肺炎而入住重症监护病房的危重病患者中,肾功能不全是一种常见的并发症,需要肾脏替代治疗的患者占 18%。需要进行 HD 的患者与较高的死亡风险相关。死亡率主要与多器官衰竭、少尿、急性肾损伤和肾功能无法恢复有关。